Showing results (71-80 of 116) with videos related to
Sort By:
Pageof 12
Haematologica|November 26, 2008
CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosisClaudio Tripodo, Andrea Di Bernardo, Maria Paola Ternullo, et al.American Journal of Clinical Pathology|August 15, 2008
The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemiaUmberto Gianelli, Alessandra Iurlo, Claudia Vener, et al.Cancers|April 12, 2022
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary MyelofibrosisDaniele Cattaneo, Claudia Vener, Elena Maria Elli, et al.International Journal of Surgical Pathology|December 20, 2002
Lymphomas of the bone: a pathological and clinical study of 54 casesUmberto Gianelli, Carlo Patriarca, Alessia Moro, et al.Critical Care Medicine|May 1, 2004
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel diseaseElena M Faioni, Stefano Ferrero, Gessica Fontana, et al.Clinical and Translational Gastroenterology|July 15, 2016
Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune EnteropathyMoira Paroni, Andrea Magarotto, Silvia Tartari, et al.American Journal of Physiology. Renal Physiology|May 6, 2025
High-phosphate causes endothelial extracellular matrix calcification by inducing endothelial cell mesenchymal transition and osteoblastic differentiationPaola Ciceri, Luisa Artioli, Martina Molinaro, et al.Journal of Lipid Research|February 11, 2024
Loss of function and reduced levels of sphingolipid desaturase DEGS1 variants are both relevant in disease mechanismMichele Dei Cas, Linda Montavoci, Claudia Pasini, et al.Experimental Hematology|July 27, 2010
Oxidative stress is increased in primary and post-polycythemia vera myelofibrosisClaudia Vener, Cristina Novembrino, Fabrizia Bamonti Catena, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 1, 2017
The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerationsUmberto Gianelli, Daniele Cattaneo, Anna Bossi, et al.Pageof 12